Veterinary Antibiotics Market Growth Driven by Rapid Transformation in Pharma Sector 2026; Predicted By Global Key Vendors Bayer AG, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi, Crystal Pharma, Dechra Pharmaceuticals PLC, Virbac

Antibiotics are used in livestock production to treat diseases in animals, to control infection of disease among healthy animals, to prevent disease in animals, and to increase animal productivity. Antibiotics keep poultry and livestock healthy, thereby reducing the chance of bacterial transmission from animals to humans. Majority of antibiotics drugs approved for use in food-producing animals through their feed or water are available over-the-counter.

Market Dynamics

Increasing demand for animal protein and growing demand for food production from animal source is leading driver for use of antibiotics in animal agriculture. Several countries across the world produce meat and aquaculture products. According to Organization for Economic Co-Operation and Development (OECD), an average U.S. adult consumed 198 pounds of meat in 2014. According to the WHO 2015 report, South East Asia region (SEAR) has developed intensive farming systems, leading to the rising consumption of fertilisers, antibiotics, and pesticides.

Get In-Depth Sample Copy @ https://bit.ly/2BWp19h

However, over-use and misuse of antibiotics in animals and humans is rising threat of antibiotic resistance. Therefore, governments across the globe are banning or limiting use of antibiotics in animal production and growth. For instance, in November 2018, European Union (EU) approved restrictions on Veterinary Antibiotics. The new legislation, which is expected to become law by 2022, bans use of antibiotics for animals, which are important for human medicine and prohibits use of any antimicrobials in livestock without a prescription from a veterinary doctor. In 2016, the United Nations General Assembly (UNGA) brought together the global community in declaring antimicrobial resistance (AMR) as a major concern and a global commitment to fight an issue through multi-pronged approaches.

Increasing demand for meat and poultry is expected to drive the veterinary antibiotics market revenue

Increasing demand for livestock products including meat, milk, and other animal food products worldwide is expected to boost the veterinary antibiotics market growth. Moreover, increasing incidence of diseases in livestock is likely to aid in expansion of this market. According to the United Nations 2015 report, antibiotics consumption in livestock is expected to reach 105,600 tons by 2030, globally due to increases in the number of animals raised for food production.

Furthermore, in order to meet increasing demand for animal protein, majority of the farmers are transitioning to intensive agriculture and often use antibiotics to optimize production. According to the Organisation for Economic Co-operation and Development (OECD) 2015 data, with increase in human population and increased demand for meat, estimated antibiotic use in food animals will increase by 67% globally from 2010 to 2030.

Veterinary Antibiotics Market - Competitive Landscape

Key players operating in the global veterinary antibiotics market include

1. Bayer AG
2. Boehringer Ingelheim GmbH
3. Ceva Sante Animale
4. Crystal Pharma
5. Dechra Pharmaceuticals PLC
6. Huvepharma AD
7. Eli Lilly Company
8. Elanco
9. Merck & Co., Inc.
10. Sanofi
11. Vetoquinol S.A.
12. Virbac
13. Zoetis, Inc.

Detailed Segmentation:

Global Veterinary Antibiotics Market, By Product Type:

• Anti-parasitic
• Anti-bacterial
• Non-steroidal anti-inflammatory drug
• Others

Global Veterinary Antibiotics Market, By End Use:

• Dairy Farm
• Poultry Farm
• Others

Global Veterinary Antibiotics Market, By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Do You Have Specific Requirement? Ask Our Experts @ https://bit.ly/2VubBIV

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.